Ads
related to: hyperlipidemia
Search results
Plozasiran Paves RNA Interference Path to Triglyceride Reduction
MedPage Today· 6 days agoThe liver APOC3-targeted RNA interference agent plozasiran proved its triglyceride-lowering effects...
Arrowhead's much-anticipated cholesterol drug hits the mark again in phase 2 hyperlipidemia trial
FierceBiotech· 6 days agoThe company presented results from the midstage MUIR study of plozasiran at the 92nd European...
RNA Inhibitor Is Shown Safe and Effective in Reduc | Newswise
Newswise· 5 days ago(siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been...
Triglycerides Down With ANGPTL3 RNA Interference Agent
MedPage Today· 5 days agoAn RNA interference therapy, targeting ANGPTL3 in the liver, drastically reduced fasting triglycerides in people with mixed hyperlipidemia, the ARCHES-2 trial showed. Used ...
Is coronary artery disease a genetic condition?
Medical News Today· 4 days agoWhat role does genetics play in the development of coronary artery disease? Read on to learn more, including other risk factors that may increase the...
Promising results for hyperlipidemia treatment reduce risk of cardiovascular events
Medical Xpress· 6 days agoThe results, published in the latest edition of the New England Journal of Medicine, demonstrate how the drug plozasiran works by targeting ApoC3, which is a key regulator of the lipoprotein ...
Cholesterol: How Actor Gina Torres Maintains a Healthy Level
Healthline· 5 days agoPrimetime TV star Gina Torres shares her parents’ issues with heart health. Torres is spreading...
BMO highlights Ionis Pharmaceuticals' market entry advantage in bullish stock rating By...
Investing.com· 5 days agoDespite Plozasiran's less frequent dosing schedule, BMO Capital highlighted Olezarsen's early market...
Ad
related to: hyperlipidemia